CIK 0001498382 · Non-accelerated filer<br>Smaller reporting company
TuHURA Biosciences, Inc./NV
Sign in to watch- Ticker
- HURA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 990360497
- Phone
- 813-875-6600
- Business address
- 10500 UNIVERSITY CENTER DR., SUITE 110, TAMPA, FL, 33612
- Former names
- Kintara Therapeutics, Inc., DelMar Pharmaceuticals, Inc., Berry Only Inc.
- 4 Open-market buy Director bought 2,000 shares at $0.87 ($1,740)
- 4 Open-market buy Director bought 7,500 shares at $0.91 ($6,825)
- 4 Conversion Director acquired 5,000 shares (conversion)
- 10-Q Report Quarterly Report
- 8-K Event Other events
- 4 Open-market buy Director bought 5,000 shares at $1.00 ($5,000)
- SC 13D/A Stake Beneficial Ownership Report
- SC 13D/A Stake Beneficial Ownership Report
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Executive or director change
- 4 Conversion Director acquired 10,000 shares (conversion)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 10-Q Report Quarterly Report
- 4 Conversion CEO and President acquired 22,000 shares (conversion)
- 4 Conversion Chief Scientific Officer acquired 34,000 shares (conversion)
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
Page 43 of 47 · 929 filings